Supplemental Figure 4 from WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike “Non-Alpha” Muteins

2026 Open access

Read full text
Authors: Christopher J. Nirschl, Kulandayan K. Subramanian, Heather R. Brodkin, Celesztina Domonkos, Connor J. Dwyer, Daniel J. Hicklin, RANDI E. ISAACS, Nesreen S. Ismail, Julie LePrevost, Yuka Lewis, Kristin R. Morris, Cynthia Seidel‐Dugan
+5 more Zoe Steuert, Jenna M. Sullivan, Sameer S. Chopra, Andrés Salmerón, William M. Winston
DOI: 10.1158/2326-6066.31484125
Cited by: 0

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers T-cell and B-cell Immunology

Publication details

Publication date
4 March 2026
Language
EN